Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.440
-0.060 (-4.00%)
At close: Oct 29, 2024, 4:00 PM
1.560
+0.120 (8.33%)
After-hours: Oct 29, 2024, 5:56 PM EDT
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $20.68 million as of October 29, 2024. Its market cap has increased by 87.97% in one year.
Market Cap
20.68M
Enterprise Value
8.31M
1-Year Change
87.97%
Ranking
Category
Stock Price
$1.44
Market Cap Chart
Since February 12, 2019, Chemomab Therapeutics's market cap has decreased from $71.00M to $20.68M, a decrease of -70.88%. That is a compound annual growth rate of -19.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2024 | 22.00M | 249.21% |
| Dec 29, 2023 | 6.30M | -82.93% |
| Dec 30, 2022 | 36.90M | -53.11% |
| Dec 31, 2021 | 78.70M | 514.84% |
| Dec 31, 2020 | 12.80M | 23.08% |
| Dec 31, 2019 | 10.40M | -85.35% |
| Feb 12, 2019 | 71.00M | - |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Impact BioMedical | 23.00M |
| BioVie | 22.76M |
| Cadrenal Therapeutics | 22.59M |
| Pieris Pharmaceuticals | 22.44M |
| Retractable Technologies | 22.15M |
| Lifeward | 21.93M |
| Cognition Therapeutics | 21.76M |
| ProMIS Neurosciences | 21.34M |